Aytu Bioscience Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aytu Bioscience Inc with three other
miscellaneous service companies in North America:
Antibe Therapeutics Inc
sales of 8.51 million Canadian Dollars [US$6.42 million]
India Globalization Capital, Inc.
During the year ended June of 2018, sales at
Aytu Bioscience Inc were $3.66 million.
increase of 13.6%
versus 2017, when the company's sales were $3.22 million.
This was the fourth straight year of sales growth at Aytu Bioscience Inc.